MAHER AWAD: Open Payments
NPI 1134106677 · ABERDEEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 43 payments from 4 companies in 2025. Trend: 2023 $1,830 · 2024 $1,524 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $585 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $536 |
| Teva Pharmaceuticals USA, Inc. | 1 | $57 |
| Lundbeck LLC | 2 | $29 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, REXULTI.
Industry payments across NJ — which companies pay providers there.
